Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Onto Innovation — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while Onto Innovation trades at $293.25 (market cap $14.36B). The key difference: Halozyme Therapeutics Inc. Common Stock and Onto Innovation are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Onto Innovation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Onto Innovation for 6 Days on average.
| HALO | ONTO | |
|---|---|---|
Market Cap | $12.58B | $14.36B |
Volume | 2,179,278 | 761,617 |
Sector | Health | Technology |
52-Week High | $115.22 | $378.45 |
52-Week Low | $61.63 | $121.34 |
Typical Hold Time | 1 Days | 6 Days |
Enterprise Value | $14.49B | $13.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
